[Probiotics--possibilities and limitations of their application in food, animal feed, and in pharmaceutical preparations for men and animals]
- PMID: 11766268
[Probiotics--possibilities and limitations of their application in food, animal feed, and in pharmaceutical preparations for men and animals]
Abstract
Probiotics are cultures of special microorganisms, which have been used as feed additives since the seventies of the past century and already since the twenties in food specimen and in pharmaceuticals. The definition of "Probioticum" was formulated in 1974 simultaneously with the use of living cultures in feed for various animals in order to substitute the application of nutritive antibiotics or chemotherapeutics. In the meantime probiotics are applied not only as feed supplements or pharmaceuticals but increasingly in suitable food specimens such as dairy products, fruit juices, chocolates, and even meat products. Of course, heating of such products prior to consumption or application must be ruled out. The selection of a suitable strain of a microorganism can be regarded as the primary requirement for the use as a probiotic. These cultures must be able to pass the stomach-duodenum barrier in a viable state and to multiply at the site of destination in the intestine. Additionally, they must be capable of producing antagonistic metabolites against a dominating saprophytic microflora resulting in a competitive growth. These abilities are common among lactic acid bacteria, e.g. lactobacilli and bifidobacteria. Yet, intended autochthonous species do not possess very good technological features for the enrichment in food specimens, because their viability will decrease rapidly under unfavourable conditions as it is the case with mineral supplements in feed or with low acidity in fermented dairy products. Therefore, some other microorganisms like spore-forming species or yeast cultures were introduced as probiotic components. These possess some similar features which render them suitable for probiotic use. But their physiological and ecological traits do not qualify them as probiotics of first choice. The special efficacy of probiotics must be strictly verified in animal nutrition due to restrictive EC-regulations, in pharmacy due to legal restraints, and in food applications in accordance with food law regulations. Safety aspects are considered very restrictively in feed applications, in the food and pharmaceutical sector they should be in accordance with the intended purpose of "fulfilling health claims". In the presented review the different requirements for the application of probiotics in animal nutrition, in food, and in pharmaceuticals will be provided. The special effect of competitive exclusion of pathogenetic and toxinogenic microorganisms in fowl performance are mentioned and even the application of probiotics as marine aquacultures of fish and Crustaceae will be included. Furthermore, the safety aspects resulting from the tremendous amount of industrially produced cultures which are distributed into the environment will be discussed. In conclusion it may be pointed out that probiotics may serve to partially replace the presently reduced or even prohibited application of nutritive antibiotics or chemotherapeutics in animal nutrition and in fulfillment of health claims in man and animals. Economic and environmental aspects will reduce the overall application of probiotics world-wide. Restrictions of use and controls of efficacy and safety are essential and must be implemented periodically.
Similar articles
-
Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Food Chem Toxicol. 2008. PMID: 18328408 Review.
-
Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective.Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S76-9; discussion S144-51. doi: 10.1086/523337. Clin Infect Dis. 2008. PMID: 18181728
-
Fermented products with probiotic qualities.Anaerobe. 1997 Apr-Jun;3(2-3):185-90. doi: 10.1006/anae.1997.0099. Anaerobe. 1997. PMID: 16887587
-
The use of bacterial spore formers as probiotics.FEMS Microbiol Rev. 2005 Sep;29(4):813-35. doi: 10.1016/j.femsre.2004.12.001. Epub 2004 Dec 16. FEMS Microbiol Rev. 2005. PMID: 16102604 Review.
-
Probiotics for animal nutrition in the European Union. Regulation and safety assessment.Regul Toxicol Pharmacol. 2006 Jun;45(1):91-5. doi: 10.1016/j.yrtph.2006.02.004. Epub 2006 Mar 24. Regul Toxicol Pharmacol. 2006. PMID: 16563585
Cited by
-
Probiotic Bacteria in Wound Healing; An In-Vivo Study.Iran J Biotechnol. 2019 Dec 1;17(4):e2188. doi: 10.30498/IJB.2019.85188. eCollection 2019 Dec. Iran J Biotechnol. 2019. PMID: 32671124 Free PMC article.
-
Probiotic and Functional Properties of Limosilactobacillus reuteri INIA P572.Nutrients. 2021 May 29;13(6):1860. doi: 10.3390/nu13061860. Nutrients. 2021. PMID: 34072532 Free PMC article.
-
Complete genome sequence and antimicrobial activity of Bacillus velezensis JT3-1, a microbial germicide isolated from yak feces.3 Biotech. 2020 May;10(5):231. doi: 10.1007/s13205-020-02235-z. Epub 2020 May 5. 3 Biotech. 2020. PMID: 32399381 Free PMC article.
-
Dietary Administration of Bacillus subtilis Enhances Growth Performance, Immune Response and Disease Resistance in Cherry Valley Ducks.Front Microbiol. 2016 Dec 8;7:1975. doi: 10.3389/fmicb.2016.01975. eCollection 2016. Front Microbiol. 2016. PMID: 28008328 Free PMC article.
-
Microencapsulation of Lacticaseibacillus rhamnosus GG for Oral Delivery of Bovine Lactoferrin: Study of Encapsulation Stability, Cell Viability, and Drug Release.Biomimetics (Basel). 2022 Oct 4;7(4):152. doi: 10.3390/biomimetics7040152. Biomimetics (Basel). 2022. PMID: 36278709 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous